// App-Quantinova.ai

PO‐166 : Determining the length of stay in secondary care for patients admitted with deep vein thrombosis or pulmonary embolism

Researchers

Presenter

  • H Roberts

Principal Investigators

  • CW Ngua

  • K Pink

  • M Rees

  • J Premier

  • S Webster

  • A van Doorneward

  • S Lister

  • J Gordon

  • R Alikhan

Medical Centers

  • Oxford Haemophilia and Thrombosis Centre

  • Emergency Department

  • Respiratory Medicine, University Hospital of Wales

  • Health Economics & Outcomes Research Ltd, Cardiff

  • Bristol Myers Squibb, Middlesex, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved